DOCSLIB.ORG

Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Halitosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Halitosis Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Halitosis Chemical Activity Count (+)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (+)-8HYDROXYCALAMENENE 1 (+)-ALPHA-VINIFERIN 1 (+)-AROMOLINE 1 (+)-CASSYTHICINE 1 (+)-CATECHOL 1 (+)-GALBACIN 1 (+)-T-CADINOL 1 (+)-VESTITONE 1 (-)-3-HYDROXY-9-METHOXYPTEROCARPAN 1 (-)-ACANTHOCARPAN 1 (-)-ALPHA-HYDRASTINE 1 (-)-APIOCARPIN 1 (-)-CANESCACARPIN 1 (-)-CENTROLOBINE 1 (-)-CLANDESTACARPIN 1 (-)-CRISTACARPIN 1 (-)-DEMETHYLMEDICARPIN 1 (-)-DOLICHIN-A 1 (-)-DOLICHIN-B 1 (-)-EPICATECHIN 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-GALLATE 2 (-)-GLYCEOCARPIN 1 (-)-GLYCEOFURAN 1 (-)-GLYCEOLLIN-I 1 (-)-GLYCEOLLIN-II 1 Chemical Activity Count (-)-GLYCEOLLIN-III 1 (-)-GLYCEOLLIN-IV 1 (-)-GLYCINOL 1 (-)-ISOSATIVAN 1 (-)-JASMONIC-ACID 1 (-)-KAUR-16-EN-19-OIC-ACID 1 (-)-MEDICARPIN 1 (-)-VESTITOL 1 (-)-VESTITONE 1 (15:1)-CARDANOL 1 (2Z,8Z)-10-ANGELOYLOXY-MATRICARIA-ESTER 2 (5R,8R,9S,10R)-12-OXO-ENT-3,13-CLERODIEN-15-OIC-ACID 1 (E)-2-HEXENAL 1 (Z)-1,3-BIS(4-HYDROXYPHENYL)-1,4-PENTADIENE 2 -METHOXYBRASSITIN 1 1,2,11,13,2,3'-HEXAHYDROVERNODALIN 1 1,2,4-TRIHYDROXYHEPTADECA-16-ENE 1 1,2-DIHYDROXY-4-GLUCOSYLNAPTHALENE 3 1,2-DIMETHOXY-3,8-DIHYDROXYXANTHONE 1 1,3,4,5-TETRACAFFEOYLQUINIC-ACID 1 1,3,5-TRIMETHOXYBENZENE 1 1,4-NAPTHAQUINONE 1 1,7-DIHYDROXY-4-METHOXYXANTHONE 1 1,8-CINEOLE 6 1-ACETYLJATIVATRIOL 1 1-ETHYL-BETA-CARBOLINE 1 1-MAACKIAIN 1 2 Chemical Activity Count 1-METHOXYCANTHIN-6-ONE 1 1-TULIPOSIDE-A 3 1-TULIPOSIDE-B 3 10-METHOXYCAMPTOTHECIN 1 11-DIHYDRO-CANTHINE-6-ONE 1 13',II8-BIAPIGENIN 1 15-ALPHA-ACETOXYKAUREN-19-OIC-ACID 1 15-GLUCOPYRANOSYL-GLAUCORUBOLONE 1 16-HYDROXYPSEUDOJOLKINOLIDE 1 2'-HYDROXY-4,6'-DIMETHOXY-3'-METHYLDIHYDROCHALCONE 2 2'-HYDROXYDAIDZEIN 1 2'-HYDROXYGENISTEIN 1 2,3-DEHYDROKIEVITONE 1 2,4,6-TRIMETHOXYPHENOL 1 2,4-DIHYDROXY-6-METHOXY-3-METHYL-ACETOPHENONE 1 2,4-DIHYDROXY-6-METHOXY-3-METHYL-ACETOPHENONE-2-BETA-GLUCOSIDE 1 2,6-DIMETHOXY-P-BENZOQUINONE 2 2,7-DIHYDROXYCADALENE 1 2,7-DIMETHOXY-5-ISOPROPYL-3-METHYL-8,1-NAPTHALENE-CARBOLACTONE 2 2-HEXEN-1-OL 1 2-HYDROXY-5-ISOPROPYL-7-METHOXY-3-METHYL-8,1-NAPTHALENE-CARBOLACTONE 2 2-METHOXYPHASEOLLINISOFLAVON 2 2-NAPTHOL 1 2-NONANONE 1 2-PROPENE-1-SULFINOTHIOCIC-ACIDS-2-PROPENYL-ESTER 1 26-DESGLUCOAVENACOSIDE-A 1 26-DESGLUCOAVENACOSIDE-B 1 3 Chemical Activity Count 3'-FORMYL-2',4',6'-TRIHYDROXY-5'-METHYLDIHYDROCHALCONE 2 3'-FORMYL-2',4',6'-TRIHYDROXYDIHYDROCHALCONE 1 3'-O-METHYLBATATASIN-III 1 3,4-DIHYDROXYBENZOIC-ACID 1 3,4-DIMETHOXYTOLUENE 2 3,4-SECOTRACHYLOBANOIC-ACID 4 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 3,5'-DIALLYL-2'-HYDROXY-4-METHOXYBIPHENYL-ETHER 2 3,5-BIS(3-METHYL-2-BUTENYL)-4-METHOXY-BENZOIC-ACID 1 3,5-DIMETHOXY-1,6-DIHYDROXYXANTHONE 1 3,5-DIMETHYL-4,6-DI-O-METHYLPHLOROACETOPHENONE 1 3,6A-DIHYDROXY-8,9-(METHYLENEDIOXY)-PTEROCARPAN 1 3-CARBOMETHOXY-1,8-DIHYDROXYANTHRAQUINONE 1 3-HYDROXY-8,9-(METHYLENEDIOXY)-6A,11A,DEHYDROPTEROCARPAN 1 3-HYDROXY-9-METHOXYPTEROCARPAN 1 3-METHOXY-1,8-DIHYDROXY-ANTHRQUINONE 1 3-N-BUTYROYL-BETA-IONONE 1 3-O(ALPHA-L-ARABINOPYRANOSYL(1,2))ALPHA-L-ARABINOPYRANOSYL(1-6)2-ACETOAMIDO-2- 2 DEOXY-BETA-D-GLUCOPYRANOSYL-OLEANOLIC-ACID 3-O-METHYL-(+)-CATECHIN 1 3-O-METHYL-MANGOSTIN 2 3-OXO-11-ALPHA-HYDROXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-11-ALPHA-METHOXYOLEAN-12-ENE-30-OIC-ACID 1 3-OXO-OLEAN-9(11),12-DIENE-30-OIC-ACID 1 4'-O-METHYLCOUMESTROL 1 4,15-DIHYDROVERNODALIN 1 4,4'-DIALLYL-2,3'-DIHYDROXYBIPHENYL 2 4,4'-DIALLYL-2,3'-DIHYDROXYBIPHENYL-ETHER 2 4 Chemical Activity Count 4,5-DIHYDROVERNODALIN 1 4,5-DIMETHOXY-6-(2-PROPENYL)1,3-BENZDIOXOLE 1 4,7-DIHYDROXY-2-METHOXY-9,10-DIHYDROPHENANTHRENE 1 4,8,13-DUVATRIEN-1,3-DIOL 1 4-(2-PHENYLETHYLETHYL)-PHENOL 1 4-(2-{METHOXYPHENYL}ETHYL)-PHENOL 1 4-EPIABIETIC-ACID 1 4-EPIABIETOL 1 4-HYDROXY-3(3-METHYL-2-BUTENYL)BENZOIC-ACID-METHYL-ESTER 2 4-HYDROXY-3,5-BIS(3-METHYL-2-BUTENYL)-BENZOIC-ACID 1 4-HYDROXY-3,5-BIS(3-METHYL-2-BUTENYL)BENZOIC-ACID-METHYL-ESTER 1 4-HYDROXY-3-(3-METHYL-2-BUTENYL)-5-(3-METHYL-2-BUTENYL)-BENZOIC-ACID 1 4-HYDROXY-3-(ISOPENTEN-2-YL)-ACETOPHENONE 1 4-HYDROXYBENZOYL-ERYTHRITOL 1 4-HYDROXYHOMOPTEROCARPIN 1 4-METHOXY-3,5-BIS(3-METHYL-2-BUTENYL)BENZOIC-ACID 2 4-METHOXYBRASSININ 1 4-METHYL-6-ACETOXYHEXANAL 1 4-METHYL-CATECHOL 1 5,4'-DIHYDROXY-6,7,8,3'-TETRAMETHOXYFLAVONE 1 5,6,7,8-TETRAMETHOXYFLAVONE 1 5,7,2',6'-TETRAHYDROXYFLAVONE 1 5,7,4'-TRIHYDROXY-6,8-DIPRENYLISOFLAVONE 1 5,7-DIHYDROXY-2-METHYLCHROMONE-8-C-BETA-GLUCOPYRANOSIDE 4 5,7-DIHYDROXY-3,8-DIMETHOXYFLAVONE 1 5,7-DIHYDROXYCHROMONE 1 5,8-DIHYDROXY-6,7-DIMETHOXY-FLAVANONE 1 5 Chemical Activity Count 5-(HEPTADEC-12-ENYL)-RESORCINOL 1 5-DEOXYKIEVITONE 1 5-HEXYL-CYCLOPENTA-1,3-DIONE 1 5-HYDROXY-7,4-DIMETHOXYFLAVONE 2 5-HYDROXY-7,8,3',4'-PENTAMETHOXYFLAVONE 1 5-METHOXY-PSORALEN 1 5-OCTYL-CYCLOPENTA-1,3-DIONE 1 6,6'-DIHYDROXYTHIOBINUPHARIDINE 1 6,6'-DIMETHOXYGOSSYPOL 1 6,7-DIHYDROXY-FLAVANONE 1 6-ALPHA-HYDROXYDEHYDROCOSTUS-LACTONE 1 6-ALPHA-HYDROXYMAACKIAIN 1 6-ALPHA-HYDROXYMEDICARPIN 2 6-DEMETHYLVIGNAFURAN 1 6-DEOXYJACAREUBIN 1 6-HYDROXYGENISTEIN 1 6-METHOXYGOSSYPOL 1 6-METHOXYTECLEANTHINE 2 6A,11A-DEHYDROGLYCEOLLIN 1 6A,11A-DEHYDROPISATIN 1 6A,11A-DEHYDROTUBEROSIN 1 7,4'-DIHYDROXY-8-METHYLFLAVAN 1 7,4'-DIHYDROXYFLAVAN 2 7-HYDROXY-5,6,8-TRIMETHOXY-FLAVANONE 1 7-HYDROXY-FLAVANONE 1 7-HYDROXYFLAVAN 2 7-HYDROXYFRULLANOLIDE 1 6 Chemical Activity Count 7-METHYLJUGLONE 1 7-O-(6-O-BETA-D-APIOFURANOSYL)-BETA-D-(GLUCOPYRANOSYL)-ORCHINOL 1 7-O-METHYL-GLABRANINE 1 8(14),15-SANDARACOPIMARADIEN-7ALPHA,18-DIOL 2 8-(3,3-DIMETHYLALLYL)SPATHELIACHROMENE 1 8-ALPHA-HYDROXYANHYDROVERLOROTIN 1 8-KETOCOPAENAL 1 8-KETOYLANGENAL 1 8-METHOXY-PSORALEN 3 ABIETANE-1 2 ABIETANE-2 2 ABYSSINONE-I 2 ABYSSINONE-II 1 ABYSSINONE-IV 1 ABYSSINONE-V 1 ACALYPHINE 1 ACANTHOCARPAN 1 ACEMANNAN 1 ACERIN 1 ACETALDEHYDE 1 ACETIC-ACID 2 ACETOPHENONE 2 ACETOXYCHAVICOL-ACETATE 1 ACETYLSHIKONIN 4 ACORIC-ACID 2 ACRIDONE 1 ACRIDONEPOXIDE 2 7 Chemical Activity Count ACRYLIC-ACID 2 ACTEOSIDE 1 ACTINIDINE 1 ACTINODAPHNINE 1 ADHUMULONE 1 ADHYPERFORIN 1 ADLUPULONE 1 AESCIN 2 AESCULETIN 3 AESCULIN 1 AFRORMOSIN 1 AFRORMOSINE-7-O-BETA-GALACTOSIDE 3 AGARIC-ACID 1 AGLAFOLIN 1 AGLALACTONE 1 AGLAROXIN-A 1 AGRIMOL 1 AGRIMOPHOL 1 AGROPYRENE 4 AILANTHONE 1 AJOENE 6 AKEBOSIDE 1 AKNADICINE 1 AKUAMMIDINE 1 ALANTOLACTONE 4 ALBAFURAN-A 1 ALIZARIN 1 8 Chemical Activity Count ALIZARIN-2-METHYL-ETHER 1 ALKANNIN 2 ALKYL-THIOSULFINATE 2 ALLICIN 5 ALLIIN 2 ALLISTATIN 2 ALLISTATIN-I 1 ALLISTATIN-II 1 ALLOALANTOLACTONE 2 ALLOIMPERATORIN 1 ALLYL-1-PROPENYL-THIOSULFINATE 1 ALLYL-2-PROPENE-L-THIOSULFINATE 2 ALLYL-ISOTHIOCYANATE 2 ALLYL-METHYLTHIOCYANATES 3 ALLYL-SULFIDE 1 ALLYLPYROCATECHOL 1 ALMUNEQUINE 1 ALOE-EMODIN 4 ALPHA-BISABOLOL 4 ALPHA-CHACONINE 1 ALPHA-CITRAL 1 ALPHA-HEDERIN 2 ALPHA-HYDRASTINE 1 ALPHA-PHELLANDRENE 2 ALPHA-PINENE 2 ALPHA-SOLANINE 1 ALPHA-TERPINEOL 2 9 Chemical Activity Count ALPHA-TERTHIENYL 4 ALPHA-THUJONE 1 ALSTONINE 2 ALUMINUM 1 AMENTOFLAVONE 1 AMMORESINOL 1 AMORFRUTIN 1 AMORPHASTILBOL 1 AMPELOPSIN 1 AMPHIBINE 2 ANACARDIC-ACID 3 ANDROGLYCINOL 1 ANDROGRAPHOLIDE 1 ANEMONIN 2 ANETHOLE 5 ANHYDROGLYCINOL 1 ANISALDEHYDE 1 ANISIC-ACID 2 ANNONOQUINONE-A 1 ANNUITHRIN 1 ANNULOLINE 1 ANONAINE 4 ANTHOCYANIDINS 1 ANTHOMINE 1 ANTIRRHINOSIDE 1 ANTOFINE 3 APIGENIN 1 10 Chemical Activity Count APIGENINIDIN 1 APIOCARPIN 1 APPARACINE 1 APPARICINE 3 ARABINOSYL-5-O-APIGENINIDIN-CAFFEIC-ACID-ESTER 1 ARALIONINE 2 ARBORINE 1 ARBUTIN 3 ARCTIOPICRIN 1 ARDISINOL-I 1 ARDISINOL-II 1 ARECOLINE 1 ARENARIN 1 ARENARINE 1 ARENOPHTHALIDE-A 1 ARGENTATINE-A 2 ARISTOLACTAM-IA 1 ARISTOLOCHIC-ACID 2 ARISTOLOCHIC-ACID-I 1 ARMILLOL 1 ARNEBIN 1 AROMADENDRENE 1 AROMADENDRIN 1 AROMADENDRIN-7-GALACTOSIDE 2 ARTARINE 1 ARTEANNUIN-B 3 ARTEMISIC-ACID 1 11 Chemical Activity Count ARVENSAN 1 ASARININ 1 ASARONE 1 ASCARIDOLE 1 ASCORBIC-ACID 3 ASIATICOSIDE 1 ASPIDISTRIN 2 ASPIDOSPERMINE 1 ASTRACICERAN 1 ASTRINGIN 1 ATHONIN 2 ATOMARIC-ACID 1 ATRACTYLENOLIDE-I 1 ATRACTYLENOLIDE-II 1 ATRACTYLENOLIDE-III 1 ATRACTYLODIN 2 ATRANORIN 2 AUCUBIGENIN 2 AUCUBIN 2 AUCUPARIN 1 AURAPTENAL 1 AVENACIN 1 AVENACINE-A 2 AVENACINE-B 1 AVENACOSIDE-B2 1 AVENACOSIDES 1 AVENALUMIN 1 12 Chemical Activity Count AVICULARIN 1 AZETIDINE-2-CARBOXYLIC-ACID 1 AZULENE 2 BAICALEIN 3 BAICALEIN-5,6,7-TRIMETHYL-ETHER 1 BAKUCHINOL 1 BAKUCHIOL 2 BALANITIN 1 BARBALOIN 1 BATATASIN 1 BAYOGENIN 1 BAYOGENIN (GLYCOSIDE) 1 BAZZANENOL 2 BELLIDIFOLIN 1 BELLIDIFOLINE 1 BELLISSAPONIN 2 BENZALDEHYDE 3 BENZOIC-ACID 4 BENZOIN 1 BENZOXAZOLINONE 1 BENZYL-2-FURYLACETYLENE 1 BENZYL-2-HYDROXYETHYL-TRISULFIDE 1 BENZYL-ALCOHOL 2 BENZYL-ISOTHIOCYANATE 3 BENZYL-THIOCYANATE 1 BERBAMINE 2 BERBERASTINE 6 13 Chemical Activity Count BERBERINE 6 BERBERINE-SULFATE 1 BETA,BETA-DIMETHYLACRYLSHIKONINE 1 BETA-AMIRINE 1 BETA-CITRAL 1 BETA-IONONE 2 BETA-PHELLANDRENE 1 BETA-PHENYLETHANOL 1 BETA-PINENE 2 BETA-RESERCYCLIC-ACID 1 BETA-SITOSTEROL 2 BETA-THUJONE 1 BETAGARIN 1 BETULINIC-ACID 1 BIBENZYL-ORCHINOL 2 BIFLORIN 4 BIFLORINE 2 BILOBALIDE 1 BILOBOL 1 BIOCHANIN-A 2 BIS-ISODIOSPYRIN 1 BLESTRIARENE-B 1 BOA 1 BONDENOLIDE 3 BORNEOL 4 BORNYL-ACETATE 1 BORRECAPINE 1 14 Chemical Activity Count BORRELINE 1 BORRERINE 2 BORREVERINE 2 BROMELAIN 2 BROMOPHENOLS 2 BROUSSIN 1 BROUSSONIN 2 BRUCEANTIN 2 BRUCEONOL-F 2 BRUCEOSIDE-D 2 BRYOPHYLLINE 2 BUDMUNCHIAMINE-A 1 BUDMUNCHIAMINE-G 1 BUDMUNCHIAMINE-K 1 BUDMUNCHIAMINES 1 BUTYL-PHTHALIDE 1 CAFFEIC-ACID 3 CAFTARIC-ACID 1 CAJANIN 1 CAJANOL 1 CAJANONE 1 CAMELLIDIN 1 CAMELLIDIN-I 1 CAMELLIDIN-II 1 CAMPHOR 2 CANALICULATOL 1 CANAVANINE 2 15 Chemical Activity Count CANDICANDIOL 1 CANELIAL 1 CANESCACARPIN 1 CANNABIDIOL 2 CANNABIDIOLIC-ACID 1 CANNABIGEROL 1 CANNABIGEROLIC-ACID 1 CANNELAL 2 CANTHIN-6-ONE 3 CANTHIUMINE 1 CAPILLIN
Load more

Recommended publications
  • Phytoalexins: Current Progress and Future Prospects
    Phytoalexins: Current Progress and Future Prospects Edited by Philippe Jeandet Printed Edition of the Special Issue Published in Molecules www.mdpi.com/journal/molecules Philippe Jeandet (Ed.) Phytoalexins: Current Progress and Future Prospects This book is a reprint of the special issue that appeared in the online open access journal Molecules (ISSN 1420-3049) in 2014 (available at: http://www.mdpi.com/journal/molecules/special_issues/phytoalexins-progress). Guest Editor Philippe Jeandet Laboratory of Stress, Defenses and Plant Reproduction U.R.V.V.C., UPRES EA 4707, Faculty of Sciences, University of Reims, PO Box. 1039, 51687 Reims cedex 02, France Editorial Office MDPI AG Klybeckstrasse 64 Basel, Switzerland Publisher Shu-Kun Lin Managing Editor Ran Dang 1. Edition 2015 MDPI • Basel • Beijing ISBN 978-3-03842-059-0 © 2015 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons Attribution 3.0 license (http://creativecommons.org/licenses/by/3.0/), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, the dissemination and distribution of copies of this book as a whole is restricted to MDPI, Basel, Switzerland. III Table of Contents About the Editor ............................................................................................................... VII List of
    [Show full text]
  • ABSTRACT Title of Document: BIOLOGICAL
    ABSTRACT Title of Document: BIOLOGICAL EFFICACY, MECHANISMS OF ACTIONS OF SOY-DERIVED PHYTOALEXIN GLYCEOLLINS IN PREVENTION OF CHRONIC DISEASES Haiqiu Huang, Doctor of Philosophy, 2014 Directed By: Professor Liangli (Lucy) Yu Department of Nutrition and Food Science Cardiovascular disease (CVD) is the leading cause of deaths worldwide. Prostate cancer is the most prevalent cancer in U.S. male population. Diet-induced hypercholesterolemia and chronic inflammation promote the development of both CVD and prostate cancer. Glyceollins are a group of soy phytoalexins possessing a variety of biological activities. This research project focused on characterizing glyceollins’ bioactivities in alleviating cholesterol dysregulation, prevention of prostate cancer, and regulating gut microbiome. The first part of the project aimed to evaluate glyceollins’ cholesterol- lowering effect in-vivo. Male golden Syrian hamsters were fed high-fat diet with or without glyceollins supplementation for 28 days. Glyceollins supplementation led to a significant reduction of plasma VLDL, hepatic cholesterol esters and total lipid content. Consistent with changes in circulating cholesterol, glyceollins supplementation also altered expression of the genes related to cholesterol metabolism in the liver. The second part of the study aimed to evaluate glyceollins’ effect in reducing prostate cancer tumor growth in a xenograft model. An initial delayed appearance of tumor was observed in a PC-3 xenograft model. However, no difference in tumor sizes was observed in a LNCaP xenograft model. Extrapolation analysis of tumor measurements indicated that no difference in sizes was expected for both PC-3 and LNCaP tumors. Glyceollins had no effect on the androgen responsive pathway, its proliferation, cell cycle, or on angiogenesis genes in tumor and xenobiotic metabolism, cholesterol transport, and inflammatory cytokine genes in liver.
    [Show full text]
  • Treatment Repurposing for Inflammatory Bowel Disease Using Literature-Related Discovery and Innovation Kostoff RN, Briggs MB, Shores DR
    ISSN 1007-9327 (print) ISSN 2219-2840 (online) World Journal of Gastroenterology World J Gastroenterol 2020 September 7; 26(33): 4889-5059 Published by Baishideng Publishing Group Inc World Journal of W J G Gastroenterology Contents Weekly Volume 26 Number 33 September 7, 2020 FRONTIER 4889 Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation Kostoff RN, Briggs MB, Shores DR REVIEW 4900 Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells Polidoro MA, Mikulak J, Cazzetta V, Lleo A, Mavilio D, Torzilli G, Donadon M MINIREVIEWS 4919 Exploring the food-gut axis in immunotherapy response of cancer patients Russo E, Nannini G, Dinu M, Pagliai G, Sofi F, Amedei A ORIGINAL ARTICLE Basic Study 4933 Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice Bluemel S, Wang Y, Lee S, Schnabl B 4945 Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy Pan HH, Zhou XX, Ma YY, Pan WS, Zhao F, Yu MS, Liu JQ Retrospective Study 4960 Effects of denosumab treatment in chronic liver disease patients with osteoporosis Saeki C, Saito M, Oikawa T, Nakano M, Torisu Y, Saruta M, Tsubota A 4972 Bowel function and quality of life after minimally invasive colectomy with D3 lymphadenectomy for right- sided colon adenocarcinoma Lee KM, Baek SJ, Kwak JM, Kim J, Kim SH 4983 Acute liver failure and death
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0165636A1 Hasebe Et Al
    US 2006O165636A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0165636A1 HaSebe et al. (43) Pub. Date: Jul. 27, 2006 (54) HAIR TREATMENT COMPOSITION AND (52) U.S. Cl. .......................................................... 424/70.14 HAIR COSMETC FOR DAMAGED HAIR (76) Inventors: Kouhei Hasebe, Gifu (JP); Kikumi (57) ABSTRACT Yamada, Gifu (JP) Correspondence Address: The present invention intends to provide a composition for FRISHAUF, HOLTZ, GOODMAN & CHICK, PC hair treatment containing Y-polyglutamic acid or a salt 220 Fifth Avenue thereof, a hair cosmetic for damaged hair containing Such a 16TH Floor composition, and their uses. The composition for hair treat NEW YORK, NY 10001-7708 (US) ment containing Y-polyglutamic acid or a salt thereof and the hair cosmetic for damaged hair of the present invention have (21) Appl. No.: 10/547,492 excellent improvement effects on the strength and frictional (22) PCT Filed: Mar. 3, 2004 force of hair, so that they can provide tension, elasticity, or the like to damage hair to prevent or alleviate split hair and (86). PCT No.: PCT/PO4/O2606 broken hair as well as improvements in combing and touch. (30) Foreign Application Priority Data Furthermore, they also exert effects of moisture retention inherent to Y-polyglutamic acid or a salt thereof, preventing Mar. 10, 2003 (JP)......................................... 2003-62688 or improving effects on the generation of dandruff on the basis of such effects, preventing effects on the feeling of Publication Classification Stickiness or creak, and various effectiveness including (51) Int. Cl. appropriate residual tendency to hair in a simultaneous A6 IK 8/64 (2006.01) manner, respectively.
    [Show full text]
  • Incorporation of Elastase Inhibitor in Silk Fibroin Nanoparticles for Transdermal Delivery
    Universidade do Minho Escola de Engenharia Ana Vanessa Fernandes Ferreira Incorporation of Elastase Inhibitor in Silk Fibroin Nanoparticles for Transdermal Delivery Incorporation of Elastase Inhibitor in Silk Fibroin DeliveryNanoparticles for Transdermal Ana Vanessa Fernandes Ferreira Fernandes Ana Vanessa Uminho | 2013 Uminho Outubro de 2013 Universidade do Minho Escola de Engenharia Ana Vanessa Fernandes Ferreira Incorporation of Elastase Inhibitor in Silk Fibroin Nanoparticles for Transdermal Delivery Dissertação de Mestrado Mestrado em Bioengenharia Trabalho efetuado sob a orientação do Professor Doutor Artur Cavaco Paulo e coorientação de Doutora Ana Sofia Lemos Machado Abreu Outubro de 2013 DECLARAÇÃO Nome: Ana Vanessa Fernandes Ferreira Endereço eletrónico: [email protected] Título da dissertação: Incorporação de Inibidor de Elastase em Nanopartículas de Fibroína de Seda para Aplicações Transdérmicas (Incorporation of Elastase Inhibitor in Silk Fibroin Nanoparticles for Transdermal Delivery) Orientador (es): Professor Artur Cavaco Paulo e Ana Sofia Lemos Machado Abreu Ano de conclusão: 2013 Designação do Mestrado: Mestrado em Bioengenharia É AUTORIZADA A REPRODUÇÃO INTEGRAL DESTA TESE/TRABALHO APENAS PARA EFEITOS DE INVESTIGAÇÃO, MEDIANTE DECLARAÇÃO ESCRITA DO INTERESSADO, QUE A TAL SE COMPROMETE. Universidade do Minho, 29/11/2013 Assinatura: ____________________________________________________________________________ No amount of experimentation can ever prove me right; a single experiment can prove me wrong. - Albert Einstein To my beloved family Este trabalho não teria sido possível sem a colaboração das pessoas que me ajudaram a concretizá-lo,Agradecimentos tanto a nível profissional / Acknoledgments como pessoal. Agradeço ao meu orientador, Professor Dr. Artur Cavaco Paulo, pela oportunidade de ingressar no seu grupo de trabalho e neste projeto de investigação, por ter confiado e acreditado nas minhas capacidades e potencial, pelo seu apoio e incentivo nestes últimos dois anos.
    [Show full text]
  • Gmmyb176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 6-28-2017 12:00 AM GmMYB176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean Arun Kumaran Anguraj Vadivel The University of Western Ontario Supervisor Dr. Sangeeta Dhaubhadel The University of Western Ontario Joint Supervisor Dr. Mark Bernards The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Arun Kumaran Anguraj Vadivel 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Molecular Biology Commons, and the Plant Biology Commons Recommended Citation Anguraj Vadivel, Arun Kumaran, "GmMYB176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean" (2017). Electronic Thesis and Dissertation Repository. 4639. https://ir.lib.uwo.ca/etd/4639 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. i Abstract MYB transcription factors are one of the largest transcription factor families characterized in plants. They are classified into four types: R1 MYB, R2R3 MYB, R3 MYB and R4 MYB. GmMYB176 is an R1MYB transcription factor that regulates Chalcone synthase (CHS8) gene expression and isoflavonoid biosynthesis in soybean. Silencing of GmMYB176 suppressed the expression of the GmCHS8 gene and reduced the accumulation of isoflavonoids in soybean hairy roots. However, overexpression of GmMYB176 does not alter either GmCHS8 gene expression or isoflavonoid levels suggesting that GmMYB176 alone is not sufficient for GmCHS8 gene regulation.
    [Show full text]
  • Biomolecules of Interest Present in the Main Industrial Wood Species Used in Indonesia-A Review
    Tech Science Press DOI: 10.32604/jrm.2021.014286 REVIEW Biomolecules of Interest Present in the Main Industrial Wood Species Used in Indonesia-A Review Resa Martha1,2, Mahdi Mubarok1,2, Wayan Darmawan2, Wasrin Syafii2, Stéphane Dumarcay1, Christine Gérardin Charbonnier1 and Philippe Gérardin1,* 1Université de Lorraine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Laboratoire d'Etudes et de Recherche sur le Matériau Bois, Nancy, France 2Department of Forest Products, Faculty of Forestry and Environment, Institut Pertanian Bogor, Bogor University, Bogor, Indonesia *Corresponding Author: Philippe Gérardin. Email: [email protected] Received: 17 September 2020 Accepted: 20 October 2020 ABSTRACT As a tropical archipelagic country, Indonesia’s forests possess high biodiversity, including its wide variety of wood species. Valorisation of biomolecules released from woody plant extracts has been gaining attractive interests since in the middle of 20th century. This paper focuses on a literature review of the potential valorisation of biomole- cules released from twenty wood species exploited in Indonesia. It has revealed that depending on the natural origin of the wood species studied and harmonized with the ethnobotanical and ethnomedicinal knowledge, the extractives derived from the woody plants have given valuable heritages in the fields of medicines and phar- macology. The families of the bioactive compounds found in the extracts mainly consisted of flavonoids, stilbenes, stilbenoids, lignans, tannins, simple phenols, terpenes, terpenoids, alkaloids, quinones, and saponins. In addition, biological or pharmacological activities of the extracts/isolated phytochemicals were recorded to have antioxidant, antimicrobial, antifungal, anti-inflammatory, anti-diabetes, anti-dysentery, anticancer, analgesic, anti-malaria, and anti-Alzheimer activities.
    [Show full text]
  • Dihydromyricetin
    Last updated on May 29, 2020 Cognitive Vitality Reports® are reports written by neuroscientists at the Alzheimer’s Drug Discovery Foundation (ADDF). These scientific reports include analysis of drugs, drugs-in- development, drug targets, supplements, nutraceuticals, food/drink, non-pharmacologic interventions, and risk factors. Neuroscientists evaluate the potential benefit (or harm) for brain health, as well as for age-related health concerns that can affect brain health (e.g., cardiovascular diseases, cancers, diabetes/metabolic syndrome). In addition, these reports include evaluation of safety data, from clinical trials if available, and from preclinical models. Dihydromyricetin Evidence Summary DHM has anti-inflammatory, antioxidant, pro-autophagic, and energy metabolism regulating properties due to activation of sirtuins, AMPK, and Nrf2, but poor bioavailability hinders clinical utility. Neuroprotective Benefit: DHM shows anti-inflammatory, antioxidant, and pro-autophagy properties which reduce cognitive impairment in animal models, but a similar level of benefit to humans is unlikely due to low bioavailability. Aging and related health concerns: DHM shows anti-inflammatory and antioxidant properties, and may favorably regulate metabolism by boosting irisin levels, improving insulin sensitivity, and enhancing lipid metabolism in animals; benefits less clear in humans. Safety: DHM has a good safety record in short term RCTs and animal studies, which may be due to low bioavailability. Pharmacokinetic properties may differ across patient populations, and may have drug interactions due to projected CYP inhibition activity. 1 Last updated on May 29, 2020 Availability: OTC Dose: Therapeutic dose not Chemical formula: C15H12O8 established MW: 320.25 g/mol Half-life: 2 hours (in rats) BBB: Penetrant Clinical trials: Type 2 diabetes Observational studies: None (n=77, NAFLD (n=60) Source: PubChem What is it? Dihydromyricetin (DHM), also called ampelopsin, is the major flavonoid in Ampelopsis plants, primarily in the species grossedentata [1].
    [Show full text]
  • Cosmetic Composition Containing Polyorganosiloxane-Containing Epsilon-Polylysine Polymer, and Polyhydric Alcohol, and Production Thereof
    Europäisches Patentamt *EP001604647A1* (19) European Patent Office Office européen des brevets (11) EP 1 604 647 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: A61K 7/48, A61K 7/06, 14.12.2005 Bulletin 2005/50 A61K 7/02, C08G 81/00, C08G 77/452, C08G 77/455, (21) Application number: 05010234.2 C08L 83/10 (22) Date of filing: 11.05.2005 (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • Kawasaki, Yuji HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR Ibi-gun Gifu 501-0521 (JP) Designated Extension States: • Hori, Michimasa AL BA HR LV MK YU Gifu-shi Gifu 500-8286 (JP) • Yamamoto, Yuichi (30) Priority: 12.05.2004 JP 2004141778 5-1 Goikaigan Ichiharashi Chiba 290-8551 (JP) • Hiraki, Jun (71) Applicants: Tokyo 104-8555 (JP) • Ichimaru Pharcos Co., Ltd. Motosu-shi, Gifu 501-0475 (JP) (74) Representative: HOFFMANN EITLE • Chisso Corporation Patent- und Rechtsanwälte Osaka-shi, Osaka-fu 530-0005 (JP) Arabellastrasse 4 81925 München (DE) (54) Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof (57) It has been desired to develop a highly preserv- by reducing the amount of antibacterial preservative ative and antibacterial cosmetic composition that can agent to be used. easily be applied to both emulsion and non-emulsion There is provided a cosmetic composition compris- type cosmetics. It has also been desired to develop a ing one or a combination of two or more of polyorganosi- method of improving a preservative and/or antibacterial loxane-containing epsilon-polylysine compounds ob- effect(s) of a cosmetic composition comprising polyor- tained by reacting epsilon-polylysine with polyorganosi- ganosiloxane-containing epsilon-polylysine and there- loxane or a physiologically acceptable salt thereof, and polyhydric alcohol.
    [Show full text]
  • Transnasal Delivery of Fluoxetine HCL to Brain for Treating Depression
    Theranostics of Brain, Spine & Neural Disorders ISSN: 2641-8096 Research Article Theranostics Brain,Spine & Neural Disord Volume 4 Issue 2 - November 2019 Copyright © All rights are reserved by Avinash Ramrao Tekade DOI: 10.19080/JOJS.2019.04.555633 Transnasal Delivery of Fluoxetine HCL to Brain for Treating Depression Sagar Atmaram Aher and Avinash Ramrao Tekade* Department of Pharmaceutics and Pharmaceutical QA, Marathwada MitraMandal’s College of Pharmacy, India Submission: September 17, 2019; Published: November 15, 2019 *Corresponding author: Avinash R Tekade, Department of Pharmaceutics and Pharmaceutical QA, Marathwada Mitra Mandal’s College of Pharmacy, Thergaon, Pune, Maharashtra 411033, India Abstract The objective of this study is to formulate a mucoadhesive microemulsion containing Fluoxetine HCl as antidepressant and Cedar oil as penetration enhancer. Water titration method was used to formulate the microemulsion using two different ratios of selected surfactant and cosurfactant (Tween 80 and Propylene Glycol). The prepared microemulsion showed mean globule size of 303.84nm. The prepared microemulsion ex vivo diffusion is non-irritant for nasal mucosa which was confirmed by ciliotoxicity study using sheep nasal mucosa. It is clearly evident from study that mucoadhesive microemulsion can deliver drug for longer time, the initial release was burst release in the first hour followed by thesustained brain by for nasal next administration.three hours, and increased diffusion will definitely help in reducing dose related side effects
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0209617 A1 Lobisser Et Al
    US 20130209.617A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0209617 A1 Lobisser et al. (43) Pub. Date: Aug. 15, 2013 (54) COMPOSITIONS AND METHODS FOR USE Publication Classification IN PROMOTING PRODUCE HEALTH (51) Int. Cl. (75) Inventors: George Lobisser, Bainbridge Island, A23B 7/16 (2006.01) WA (US); Jason Alexander, Yakima, (52) U.S. Cl. WA (US); Matt Weaver, Selah, WA CPC ........................................ A23B 7/16 (2013.01) (US) USPC ........... 426/102: 426/654; 426/573; 426/601; 426/321 (73) Assignee: PACE INTERNATIONAL, LLC, Seattle, WA (US) (57) ABSTRACT (21) Appl. No.: 13/571,513 Provided herein are compositions comprising one or more of (22) Filed: Aug. 10, 2012 a stilbenoid, stilbenoid derivative, stilbene, or stilbene deriva tive and a produce coating. The resulting compositions are Related U.S. Application Data coatings which promote the health of fruit, vegetables, and/or (60) Provisional application No. 61/522,061, filed on Aug. other plant parts, and/or mitigate decay of post-harvest fruit, 10, 2011. Vegetables, and/or other plant parts. Patent Application Publication Aug. 15, 2013 Sheet 1 of 10 US 2013/0209.617 A1 | s N i has() 3 S s c e (9) SSouffley Patent Application Publication Aug. 15, 2013 Sheet 2 of 10 US 2013/0209.617 A1 so in a N s H N S N N. sr N re C c g o c (saulu) dae. Patent Application Publication Aug. 15, 2013 Sheet 3 of 10 US 2013/0209.617 A1 N Y & | N Y m N 8 Š 8 S.
    [Show full text]
  • The Science of Flavonoids the Science of Flavonoids
    The Science of Flavonoids The Science of Flavonoids Edited by Erich Grotewold The Ohio State University Columbus, Ohio, USA Erich Grotewold Department of Cellular and Molecular Biology The Ohio State University Columbus, Ohio 43210 USA [email protected] The background of the cover corresponds to the accumulation of flavonols in the plasmodesmata of Arabidopsis root cells, as visualized with DBPA (provided by Dr. Wendy Peer). The structure corresponds to a model of the Arabidopsis F3 'H enzyme (provided by Dr. Brenda Winkel). The chemical structure corresponds to dihydrokaempferol. Library of Congress Control Number: 2005934296 ISBN-10: 0-387-28821-X ISBN-13: 978-0387-28821-5 ᭧2006 Springer ScienceϩBusiness Media, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer ScienceϩBusiness Media, Inc., 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed in the United States of America (BS/DH) 987654321 springeronline.com PREFACE There is no doubt that among the large number of natural products of plant origin, debatably called secondary metabolites because their importance to the eco- physiology of the organisms that accumulate them was not initially recognized, flavonoids play a central role.
    [Show full text]